2. Search Result
Search Result
Pathways Recommended: Antibody-drug Conjugate/ADC Related
Results for "

TNFRSF4/OX40/CD134 Antibody

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

3

Inhibitory Antibodies

2

Antibodies

Cat. No. Product Name Target Research Area
  • HY-P99159
    Ivuxolimab

    		Inhibitory Antibodies Cancer
    Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4 + and CD8 + T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity .
  • HY-P990678
    Vonlerizumab

    		TNF Receptor Inflammation/Immunology
    Vonlerizumab is a CHO-expressed humanized antibody targeting TNFRSF4/OX40/CD134. Vonlerizumab carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Vonlerizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
  • HY-P990559
    BMS-986178

    		TNF Receptor Inflammation/Immunology
    BMS-986178 is a humanized antibody expressed in CHO, targeting TNFRSF4/OX40/CD134. BMS-986178 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for BMS-986178 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).